Ledger.Open graph →
SEC Form D · filed December 22, 2023

OcuTerra Therapeutics, Inc

Offering
$30.0M
Sold
$6.7M
Exemption
Rule 506(b)
Industry
Other
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

William H. Koster · Boston, MADirectorKerrie Brady · Boston, MAExec · DirectorBarbara H. Ryan · Boston, MADirectorWilliam S. Steinkrauss · Boston, MAExecRobert H. Ruffolo · Boston, MADirectorRobin H. Steele · Boston, MADirectorBrenton S. Saunders · Boston, MADirectorD. S. Edwards · Boston, MAExecDavid J. Tanzer · Boston, MAExecBruce H. Failing · Boston, MADirectorDavid J. Tanzer · Boston, MAExecBrenton S. Saunders · Boston, MADirectorKerrie Brady · Boston, MAExec · DirectorWilliam H. Koster · Boston, MADirectorBarbara H. Ryan · Boston, MADirectorRobin H. Steele · Boston, MADirectorRobert H. Ruffolo · Boston, MADirectorD. S. Edwards · Boston, MAExecBruce H. Failing · Boston, MADirectorWilliam S. Steinkrauss · Boston, MAExecManager of the Issuer Seven Hills Capital, LLC · Nashville, TNExecCristie Kerr · Napa, CADirectorErik Stevens · Napa, CAExecCraig F. Farber · New York, NYExecMatthew Joslin · Laguna Beach, CAExec · DirectorDavid West · Bethlehem, PADirectorNick Dicarlo · Bethlehem, PADirectorNickolay E. Bochilo · Greensboro, NCDirectorCindy E. Clare · Greensboro, NCDirectorE. D. Bell · Greensboro, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗